Cell and Gene Therapy Manufacturing Services Market
Cell and Gene Therapy Manufacturing Services
Market Scope: Industry Analysis, Market Size,
Growth, Trends Till 2031
Request Sample Report
Cell and Gene Therapy Manufacturing Services Market Size and Growth
The Cell and Gene Therapy Manufacturing Services market is experiencing robust growth, driven by increasing demand for innovative therapies. As of 2023, the global market size is projected to reach approximately $5 billion, with a CAGR of over 20% anticipated through the next five years, reflecting strong investments and technological advancements.
Companies Covered
(Covid 19 Impact Covered)
◍ Thermo Fisher Scientific
◍ Merck KGaA
◍ Charles River Laboratories
◍ Lonza
◍ Catalent
◍ WuXi AppTec
◍ Takara Bio Inc
◍ Nikon Corporation
◍ FUJIFILM Holdings Corporation
◍ F. Hoffmann-La Roche
◍ Oxford Biomedica Plc
◍ Cell and Gene Therapy Catapult
◍ The Discovery Labs LLC
◍ RoslinCT
◍ JRS PHARMA
◍ FinVector
◍ ABL
◍ Resilience
The cell and gene therapy manufacturing services market is competitive, featuring companies like Thermo Fisher Scientific, Lonza, and Catalent. They provide vital services such as viral vector production and clinical manufacturing, enhancing scalability and regulatory compliance. Key players report substantial revenues, fostering growth in the sector through innovative solutions and partnerships.
Market Segmentation
By Application
◍ Orthopedic Diseases
◍ Ophthalmology Diseases
◍ Infectious Diseases
◍ Others
By
Product
◍ By Cell Therapy
Allogeneic
Autologous
Viral Vector
Viral Vector ◍ Oncology Diseases ◍ Cardiovascular Diseases
By Gene Therapy
Non-viral Vector
Oligonucleotides
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
